What is STIM's current stock price?

STIM (Neuronetics, Inc.) is currently trading at $1.20 with a market cap of $83.5M.

What sector is Neuronetics, Inc. in?

Neuronetics, Inc. (STIM) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.

Is STIM a good stock to buy?

Analysts have a Buy consensus on STIM with a price target of $8.00. Check our detailed analysis for valuation, financials, and insider activity.

InvestLog

STIM Neuronetics, Inc.

Healthcare

$1.20+0.84%ClosedMarket Cap: $83.5M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

—

PEG

—

P/B

6.30

P/S

0.55

EV/EBITDA

-3.61

DCF Value

$-49.60

FCF Yield

-16.3%

Div Yield

0.0%

Margins & Returns

Gross Margin

48.0%

Operating Margin

-19.4%

Net Margin

-24.5%

ROE

-164.7%

ROA

-29.6%

ROIC

-28.7%

Financials

View All

Period	Revenue	Net Income	EPS
Q1 null	$34.5M	$-10.8M	$—
Q4 null	$41.8M	$-7.2M	$—
FY null	$149.2M	$-39.0M	$—
Q3 null	$37.3M	$-9.0M	$—

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$8.00

Target (Median)

$8.00

Target Range

$8.00 - $8.00

2 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell

Canaccord GenuityBuy

2026-03-19

Canaccord GenuityBuy

2025-08-06

Trading Activity

Insider Trades

View All

Pfanstiel Stevenofficer: Former EVP, CFO and Treasurer

SellThu May 21

Chernett Jorey10 percent owner

BuyWed May 20

Chernett Jorey10 percent owner

BuyWed May 13

BROWN FRANCIS X IIIofficer: Interim PAO

SellWed May 13

Chernett Jorey10 percent owner

BuyWed Apr 22

Company Info

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Country

Exchange

—

Beta

1.13

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

Peers

PRE